|
Kasimova A.R., Kolbin A.S.
Pharmacoeconomic analysis of apixaban use for secondary thromboprophylaxis at outpatient stage among oncological patients
|
№1 / 2024
|
|
Kamchatnov P.R., Prikazchikov S.V., Osmaeva Z.Kh., Chugunov A.V.
Improving the effectiveness of rehabilitation treatment of a patient who has suffered an ischemic stroke
|
№7 / 2023
|
|
Tarasova L.V., Kucherova N.Yu.
A case of atherotrombotic variant of ischemic stroke in Crohn’s disease patient
|
№7 / 2023
|
|
Kobzeva N.D., Gelpey M.A., Zibrova L.A., Skoropis A.V., Shchetinkina D.A.
Clinical case of a comorbid patient with ischemic brain stroke
|
№5 / 2023
|
|
Kokorin V.A., Boeva O.I.
Prevention of stroke and systemic embolism in patients with atrial fibrillation: focus on apixaban
|
№9 / 2022
|
|
Hadzegova A.B.
Place of acetylsalicylic acid in updated recommendations for the prevention of cardiovascular events
|
№8 / 2020
|
|
Solovieva E.Yu., Amelina I.P., Baranova O.A., Chekanov A.V.
Diagnostic markers of early phase of acute disorder of brain blood circulation in persons with КT-negative infarct data
|
№3 / 2020
|
|
Diakonova E.N., Vorobyova N.V., Makerova V.V.
Somatosensory evoked potentials in the diagnosis of afferent pathway disorders in patients with poststroke hemiparesis
|
№3 / 2020
|
|
N.E. Agibova, O.I. Boeva
New possibilities for personalizing prognosis in patients with nonvalvular atrial fibrillation
|
№3 / 2018
|
|
M.Ye. Statsenko, S.V. Turkina, I.A. Tyshchenko, S.V. Fabritskaya
Application of Mildronate in patients with comorbidity: focus on cardioneurology
|
№5 / 2016
|
Русский
